China Medical News

Imported drugs:
□　BIMZELX (bimekizumab) – marketed by UCB Pharma S.A.
□　MOUNJARO (tirzepatide) – new indication - marketed by Eli Lilly and Company
□　SMYRAF (peficitinib) – marketed by Astellas Pharma Inc.
□　VONVENDI (vonicog alfa) – marketed by Takeda Pharmaceuticals U.S.A., Inc.
□　VYVGART HYTRULO (efgartigimod alfa) – marketed by argenx BV
□　Methotrexate injection – marketed by Medac Gesellschaft für klinische Spezialpräparate mbH
□　Ursodeoxycholic acid oral suspension – marketed by Dr. Falk Pharma GmbH

Domestic drugs:
□　Bilessglu (chiglitazar) – new indication - marketed by Chengdu Chipscreen Pharmaceutical Ltd.
□　惠优加 - Hui You Jia (Insulin degludec and insulin aspart Injection) – marketed by Huisheng Bio-pharmacutical Co., Ltd.
□　泰爱 - Tai Ai (telitacicept) – new indication - marketed by RemeGen Co., Ltd.
□　泽元安 - Ze Yuan An (ganaxolone) – marketed by Marinus Pharmaceuticals, Inc.
□　Alfacalcidol drops – marketed by Hubei Jinluo Silk Cloth Co., Ltd.
□　Emtricitabine and tenofovir disoproxil fumarate tablets – marketed by Qilu Pharmaceutical Co., Ltd.
□　Entacapone tablets (II) – marketed by SJZ No.4 Pharmaceutical Co., Ltd.
□　Frovatriptan tablet – marketed by C.P Pharmaceutical (Qingdao) Co. Ltd.
□　Irbesartan and amlodipine besilate tablets (I) and (III) – marketed by Jiangxi Shimei Pharmaceutical Co., Ltd.
□　Meropenem and sodium chloride injection – marketed by Hunan Kelun Pharmaceutical Co., Ltd.
□　Multi-trace elements injection (III) – marketed by Yangpu Jingtai Pharmaceutical Co., Ltd.
□　Vancomycin hydrochloride capsules – marketed by Speed Safety Healthy (Hangzhou) Pharmaceutical Co., Ltd.
 
(Source: BaiPharm)